Search research articles
Contact Us
Filters
Showing results (11-20 of 193) with videos related to
Page
of 20
Sort By:
Journal of Geriatric Oncology
|
September 11, 2017
How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?
Marine Gilabert, Jean Luc Raoul, Frederique Rousseau
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2021
A letter of response to comments on 'A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers'
Frédéric Dumont, Christophe Passot, Jean-Luc Raoul
The Lancet. Gastroenterology & Hepatology
|
June 27, 2017
To TACE or not to TACE? Lessons from a negative trial
Jean-Luc Raoul, Marine Gilabert, Xavier Adhoute
Liver Cancer
|
June 20, 2014
How to define transarterial chemoembolization failure or refractoriness: a European perspective
Jean-Luc Raoul, Marine Gilabert, Gilles Piana
La Revue Du Praticien
|
May 29, 2015
[Management of localized, locally advanced and metastatic pancreatic adenocarcinoma]
Jean-Robert Delpero, Olivier Turrini, Jean-Luc Raoul
Journal of Hepatology
|
February 26, 2016
Hepatocellular carcinoma scoring and staging systems. Do we need new tools?
Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 12, 2017
Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?
Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2008
Acrokeratosis paraneoplastica (Bazex' syndrome) associated with metastatic squamous cell esophageal carcinoma
Guillaume Louvel, Elodie Vauléon, Eveline Boucher, et al.
World Journal of Hepatology
|
January 5, 2017
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma
Jean-Luc Raoul, Xavier Adhoute, Marine Gilabert, et al.
Nature Reviews. Clinical Oncology
|
April 9, 2015
Intermediate-stage HCC--upfront resection can be feasible
Alejandro Forner, Marine Gilabert, Jordi Bruix, et al.
Page
of 20
Search research articles
Search
Showing results (11-20 of 193) with videos related to
Sort By:
Page
of 20
Journal of Geriatric Oncology
|
September 11, 2017
How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?
Marine Gilabert, Jean Luc Raoul, Frederique Rousseau
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2021
A letter of response to comments on 'A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers'
Frédéric Dumont, Christophe Passot, Jean-Luc Raoul
The Lancet. Gastroenterology & Hepatology
|
June 27, 2017
To TACE or not to TACE? Lessons from a negative trial
Jean-Luc Raoul, Marine Gilabert, Xavier Adhoute
Liver Cancer
|
June 20, 2014
How to define transarterial chemoembolization failure or refractoriness: a European perspective
Jean-Luc Raoul, Marine Gilabert, Gilles Piana
La Revue Du Praticien
|
May 29, 2015
[Management of localized, locally advanced and metastatic pancreatic adenocarcinoma]
Jean-Robert Delpero, Olivier Turrini, Jean-Luc Raoul
Journal of Hepatology
|
February 26, 2016
Hepatocellular carcinoma scoring and staging systems. Do we need new tools?
Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 12, 2017
Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?
Xavier Adhoute, Guillaume Penaranda, Jean-Luc Raoul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2008
Acrokeratosis paraneoplastica (Bazex' syndrome) associated with metastatic squamous cell esophageal carcinoma
Guillaume Louvel, Elodie Vauléon, Eveline Boucher, et al.
World Journal of Hepatology
|
January 5, 2017
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma
Jean-Luc Raoul, Xavier Adhoute, Marine Gilabert, et al.
Nature Reviews. Clinical Oncology
|
April 9, 2015
Intermediate-stage HCC--upfront resection can be feasible
Alejandro Forner, Marine Gilabert, Jordi Bruix, et al.
Page
of 20